Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template

<table> Structures of: (1) PPAR<span class="inline" id=""></span> agonist pioglitazone, (2)
PPAR<span class="inline" id=""></span> agonist fenofibrate, (3) PPAR<span class="inline" id=""></span> agonist GW-501516, and (4) dual
PPAR<span class="inline" id=""></span>/<span class="inline" id=""></span> agonist
KRP-297.</table>

PPAR Research

fig1

Figure 1

Figure 1: Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template 

Figure 1 | Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template 